4DMedical Limited (FDMDF) Stock Analysis & Winston Score
4DMedical is an Australian medical technology company that makes software for measuring how well lungs work. Its main product, called XV Technology, uses a standard CT scanner to create detailed images showing how air moves through the lungs — something traditional lung tests cannot do as clearly. The company sells its technology to hospitals, radiology clinics, and military health programs, primarily in the United States and Australia. 4DMedical earns revenue by charging for each scan analyzed using its software, a model sometimes called "per-scan" or fee-for-service pricing. The company has a contract with the U.S. Department of Veterans Affairs, which gives it a meaningful foothold in a large, government-funded customer base. However, the deeply negative margins shown in recent financial periods make clear that 4DMedical is spending far more than it earns right now, and the key risk is whether it can grow scan volumes fast enough to reach profitability before needing to raise additional capital.
Winston Score: 25/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (10/30)
- Growth: Mixed (5/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Ownership data not available (not counted) (0/15)
Key Facts
Price: $2.95
Market Cap: $1.8B
Sector: Healthcare
Industry: Medical - Devices
Exchange: Other OTC
